Empresa Neovasc Inc.
Acciones
NVCN
CA64065J4037
Equipo médico y tecnología avanzada
Resumen de negocios
Número de empleados: 60
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Sarah Gallagher
CTO | Chief Tech/Sci/R&D Officer | - | 13/07/21 |
Shmuel Banai
CTO | Chief Tech/Sci/R&D Officer | - | - |
Alexei J. Marko
BRD | Director/Board Member | 56 | 12/06/03 |
Investor Relations Contact | 54 | 02/04/07 | |
Lisa Becker
LAW | General Counsel | - | 13/07/21 |
John Panton
PRN | Corporate Officer/Principal | - | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Steven Rubin
CHM | Chairman | 63 | 01/02/08 |
Paul Geyer
BRD | Director/Board Member | 61 | 02/11/00 |
Alexei J. Marko
BRD | Director/Board Member | 56 | 12/06/03 |
Douglas Janzen
BRD | Director/Board Member | 56 | 02/06/05 |
Norman J. Radow
BRD | Director/Board Member | - | 16/09/19 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 2 783 553 | 2 556 708 ( 91,85 %) | 0 | 91,85 % |
Información de la empresa
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
+7,62 % | 219 mil M | |
+6,70 % | 183 mil M | |
+11,94 % | 132 mil M | |
+24,60 % | 106 mil M | |
-2,66 % | 62,09 mil M | |
+4,81 % | 50,88 mil M | |
+11,55 % | 50,8 mil M | |
-1,09 % | 40,64 mil M | |
+26,82 % | 31,59 mil M |